Synapharm

Synapharm is a biopharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for central nervous system (CNS) disorders. The company's research is centered on the biology of synaptic plasticity and repair, particularly the role of the Wnt signaling pathway in maintaining neuronal connectivity. By modulating these pathways, Synapharm aims to treat neurodegenerative diseases such as Alzheimer's and neuropsychiatric conditions like major depressive disorder. The company leverages a proprietary drug discovery platform to identify compounds that can restore synaptic function and promote neural circuit recovery. Synapharm maintains operations in both Shanghai, China, and San Diego, California, benefiting from strong academic ties and venture backing from prominent life science investors.